Basics Viatris Inc. IPO Date: November 13, 2020 Sector: Healthcare Industry: Pharma Market Cap: $10.48B Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 1.31% Avg Daily Range (30 D): $0.10 | 1.12% Avg Daily Range (90 D): $0.14 | 1.60% Institutional Daily Volume Avg Daily Volume: 8.34M Avg Daily Volume (30 D): 7.54M Avg Daily Volume (90 D): 10.21M Trade Size Avg Trade Size (Sh.): 192 Avg Trade Size (Sh.) (30 D): 190 Avg Trade Size (Sh.) (90 D): 207 Institutional Trades Total Inst.Trades: 8,138 Avg Inst. Trade: $4.51M Avg Inst. Trade (30 D): $4.62M Avg Inst. Trade (90 D): $5.69M Avg Inst. Trade Volume: .39M Avg Inst. Trades (Per Day): 6 Market Closing Trades Avg Closing Trade: $17.04M Avg Closing Trade (30 D): $18.77M Avg Closing Trade (90 D): $26.69M Avg Closing Volume: 1.5M     News Jun 6, 2025 @ 5:31 PM Goldman Sachs Bullish On Branded Drug Upside At Te... Source: Vandana Singh Jun 2, 2025 @ 8:00 PM VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman... Source: Bronstein, Gewirtz & Grossman, Llc Jun 2, 2025 @ 12:00 PM Opus Genetics Announces LYNX-2 Phase 3 Trial Met i... Source: N/A May 31, 2025 @ 11:07 AM VTRS CLASS NOTICE: Viatris Inc. Investors may have... Source: N/A May 29, 2025 @ 11:22 PM VTRS DEADLINE: ROSEN, A RANKED AND LEADING LAW FIR... Source: N/A Financials   TTM Q3 2024 Q2 2024 Basic EPS $-2.55 $.08 $-.27 Diluted EPS $-2.55 $.08 $-.27 Revenue $ 3.25B $ 3.75B $ 3.8B Gross Profit $ 1.16B $ 1.46B $ 1.45B Net Income / Loss $ -3042M $ 94.8M $ -326.4M Operating Income / Loss $ -2882.2M $ 225.9M $ -239.9M Cost of Revenue $ 2.09B $ 2.29B $ 2.35B Net Cash Flow $ 20.2M $ 961.6M $ -97.4M PE Ratio     Splits Oct 09, 2003:   3:2 Jan 28, 2003:   3:2